Nymbl Science, Inc. — Form D
Nymbl Science, Inc. of Denver, CO, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-07. The offering totals $4.0M, of which $3.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-10-07
- Form: D
- Accession: 0001781552-20-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $3.7M
- Remaining: $240K
- Minimum investment: $4K
- Investors: 22
- Date of first sale: 2020-09-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-377340
Issuer
- Name: Nymbl Science, Inc.
- CIK: 0001781552
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 2000 S Colorado Blvd, Denver, CO, 80222
- Phone: 650-233-4548
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| James Cook | Director | Issaquah, WA |
| James Cook | Promoter | Issaquah, WA |
| Dr. Jean-Pierre Farcy | Promoter | Denver, CO |
| Caroline Owen-Jones | Promoter | Denver, CO |
| Thomas Virden | Promoter | Denver, CO |
| Thomas Virden | Director | Denver, CO |
| Thomas Virden | Executive Officer | Denver, CO |
| Ben Wire | Director | Denver, CO |
| Edward Likovich | Director | Denver, CO |
| Edward Likovich | Executive Officer | Denver, CO |
| Edward Likovich | Promoter | Denver, CO |
| Chris Saxman | Director | Denver, CO |
| Rohit Seth | Director | Denver, CO |
| Meghan Oliver | Director | Denver, CO |
| David Eichler | Director | Denver, CO |
| James Cook | Executive Officer | Issaquah, WA |
| Philip Linville | Director | Denver, CO |
| Carol Owens Jones | Promoter | Denver, CO |
Other filings by this issuer (4)
More